Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

8.0K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
8.0K
Tumor Progression02:07

Tumor Progression

3.6K
3.6K
Metastasis02:30

Metastasis

7.0K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
7.0K
Metastasis02:30

Metastasis

3.9K
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anticoagulation for Cancer Patients in Special Situations: A Narrative Review of Guidelines and Literature.

Cancers·2026
Same author

Recommendations for the development of an integrated lung cancer care process: an expert consensus report.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same author

Real-world evidence in localized and locally advanced prostate cancer: applying artificial intelligence to electronic health records.

BMC cancer·2025
Same author

Prevalence and management of castration-resistant prostate cancer of unknown metastatic status in the real-world setting: The AfroDiTA study.

Urologic oncology·2024
Same author

Characterization of HER2-low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study.

Cancer·2024
Same author

Amivantamab Compared with Real-World Physician's Choice after Platinum-Based Therapy from a Pan-European Chart Review of Patients with Lung Cancer and Activating <i>EGFR</i> Exon 20 Insertion Mutations.

Cancers·2023

Related Experiment Video

Updated: Apr 18, 2026

Electromagnetic Navigation Transthoracic Nodule Localization for Minimally Invasive Thoracic Surgery
07:30

Electromagnetic Navigation Transthoracic Nodule Localization for Minimally Invasive Thoracic Surgery

Published on: May 4, 2022

3.9K

Metronomics for thymic carcinoma.

Jacobo Muñoz Del Toro1, Patricia Cortez Castedo1, Alfonso Cortés Salgado1

  • 1Medical Oncology Department, Hospital Universitario Ramón y Cajal, Ctra de Colmenar Viejo km 9, Madrid 28034, Spain.

Ecancermedicalscience
|January 28, 2015
PubMed
Summary
This summary is machine-generated.

Advanced thymic carcinoma is aggressive, with limited treatment options beyond first-line chemotherapy. This case study shows a partial response in stage IV thymic carcinoma during the seventh line of treatment using an oral regimen.

Keywords:
metronomicsrecurrent thymic carcinomatreatment

More Related Videos

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.4K
High-Resolution Ultrasonography for the Analysis of Orthotopic ATC Tumors in a Genetically Engineered Mouse Model
03:41

High-Resolution Ultrasonography for the Analysis of Orthotopic ATC Tumors in a Genetically Engineered Mouse Model

Published on: October 11, 2022

2.4K

Related Experiment Videos

Last Updated: Apr 18, 2026

Electromagnetic Navigation Transthoracic Nodule Localization for Minimally Invasive Thoracic Surgery
07:30

Electromagnetic Navigation Transthoracic Nodule Localization for Minimally Invasive Thoracic Surgery

Published on: May 4, 2022

3.9K
Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.4K
High-Resolution Ultrasonography for the Analysis of Orthotopic ATC Tumors in a Genetically Engineered Mouse Model
03:41

High-Resolution Ultrasonography for the Analysis of Orthotopic ATC Tumors in a Genetically Engineered Mouse Model

Published on: October 11, 2022

2.4K

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Medical Research

Background:

  • Thymomas are common anterior mediastinum tumors, but thymic carcinoma is rare and aggressive.
  • Advanced thymic carcinoma lacks randomized trial evidence for subsequent treatment lines, making management challenging.
  • Current first-line treatment for advanced stages involves combination chemotherapy.

Observation:

  • A patient with stage IV thymic carcinoma was treated with multiple lines of therapy.
  • The patient received an oral regimen during the seventh line of treatment.
  • Radiological assessment was used to monitor treatment response.

Findings:

  • A partial radiological response was observed in the seventh line of treatment.
  • The oral regimen demonstrated efficacy in a heavily pre-treated thymic carcinoma case.
  • This suggests potential for oral therapies in advanced thymic carcinoma management.

Implications:

  • This case highlights a potential treatment avenue for refractory thymic carcinoma.
  • Further research into oral regimens for advanced thymic carcinoma is warranted.
  • This finding may inform future clinical trial designs for thymic malignancies.